Purity >85%, by SDS-PAGE under reducing conditions and visualized by silver stain. MW (observed): 50-60 kDa, reducing conditions. MW (theoretical): 58 kDa. The Recombinant Human XIAP (Full Length) Protein from R&D Systems is derived from E. coli. The Recombinant Human XIAP (Full Length) Protein has been validated for the following applications: Inhibition Activity.
Size
50 ug
Concentration
n/a
Applications
Inhibition Activity
Other Names
API3X-linked inhibitor of apoptosis protein, apoptosis inhibitor 3, baculoviral IAP repeat-containing 4, baculoviral IAP repeat-containing protein 4, BIRC4, BIRC4XLP2, E3 ubiquitin-protein ligase XIAP, EC 6.3.2.-, hIAP3, hIAP-3, hILP, IAP3, IAP-3, IAP-like protein, ILP, ILP1, Inhibitor of apoptosis protein 3, MIHA, X-linked IAP, X-linked inhibitor of apoptosis